February 26, 2017 8:27 PM ET


Company Overview of Genzyme Corporation

Key Executives for Genzyme Corporation

NameBoard RelationshipsTitleAge
David P. Meeker M.D.10 RelationshipsChief Executive Officer and President61
Marc Esteva No RelationshipsChief Financial Officer--
Scott A. Canute 78 RelationshipsExecutive Vice President and President of Manufacturing & Corporate Operations55
John G. Schulte No RelationshipsPresident of Surgical Products67
William Aitchison No RelationshipsHead of Global Industrial Operations--
View More Key Executives

Genzyme Corporation Board Members*

NameBoard RelationshipsPrimary CompanyAge
Christopher A. Viehbacher 119 Relationshipssanofi-aventis Pakistan Limited56
Henri A. Termeer 298 RelationshipsSanofi Biosurgery Inc.70
Charles Leland Cooney Ph.D. 168 RelationshipsMitra Biotech Pvt Ltd72
Cornelius McGillicuddy III 39 RelationshipsH. Lee Moffitt Cancer Center & Research Institute75
Gail Koziara Boudreaux 43 RelationshipsNovavax, Inc.55
View All Board Members

Genzyme Corporation Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Robert J. Bertolini65 Relationships6 Executives
Compensation Committee Ph.D.Charles Leland Cooney168 Relationships5 Executives
Nominating Committee IIICornelius McGillicuddy39 Relationships4 Executives
Corporate Governance Committee IIICornelius McGillicuddy39 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$573.2K
Total Value of Options
Compensation as of Fiscal Year
Genzyme Corporation CEO Compensation
Industry Average


Rigel Pharmaceuticals, Inc. Announces Board Changes
February 24, 2017 10:24 PM ET
Sangamo Therapeutics, Inc. Announces Termination of Dale Ando as Chief Medical Officer
February 24, 2017 10:10 PM ET
Ian Smith Notifies Ophthotech Corporation Request Not to Be Nominates for Re-Election to the Board of Directors
February 24, 2017 9:14 PM ET
Santhera Pharmaceuticals Opens of U.S. Office in Burlington, MA; Appoints Todd Bazemore to Lead U.S. Operations in Burlington, MA
February 24, 2017 1:30 PM ET
Celgene Corporation Announces Management Changes
February 23, 2017 10:29 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Genzyme Corporation, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.